Literature DB >> 1911546

The specificity of alloreactive T cells is determined by MHC polymorphisms which contact the T cell receptor and which influence peptide binding.

G Lombardi1, L Barber, S Sidhu, J R Batchelor, R I Lechler.   

Abstract

The separate contributions to allorecognition of peptide-binding and T cell receptor-contacting residues of an allogeneic HLA-DR molecule were investigated by site-directed mutagenesis. Alloreactive T cell clones were generated from a combination of responder (DR1Dw1,DR4Dw14) and stimulator (DR1Dw1, DR4Dw10) whose DR products differed at only three amino acid positions, two of which are predicted to interact with the T cell receptor (67 and 70), and one with bound peptide (71). Transfected murine DAP.3 cells expressing the wild type and mutated forms of DR4Dw10 in which the codons for residues 70 and/or 71 had been altered towards DR4Dw14 were used to stimulate a panel of anti-DR4Dw10 T cell clones. Substitutions at either position 70 or 71, or the combination of the two, led to loss of recognition by the alloreactive T cell clones. This implies that residues involved in peptide binding and residues involved in interaction with the T cell receptor are important for this panel of alloreactive T cell clones. The specificity of these alloreactive T cells for exposed polymorphic residues on the allogeneic MHC molecule was further demonstrated by the inhibitory effects of synthetic peptides, derived from the alpha-helix of the beta 1 domain of the DR4Dw10 molecule.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1911546     DOI: 10.1093/intimm/3.8.769

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  9 in total

1.  HLA-A amino acid polymorphism and delayed kidney allograft function.

Authors:  Malek Kamoun; John H Holmes; Ajay K Israni; Jane D Kearns; Valerie Teal; Wei Peter Yang; Sylvia E Rosas; Marshall M Joffe; Hongzhe Li; Harold I Feldman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-24       Impact factor: 11.205

2.  Employing a recombinant HLA-DR3 expression system to dissect major histocompatibility complex II-thyroglobulin peptide dynamism: a genetic, biochemical, and reverse immunological perspective.

Authors:  Eric M Jacobson; Heyi Yang; Francesca Menconi; Rong Wang; Roman Osman; Luce Skrabanek; Cheuk Wun Li; Mohammed Fadlalla; Alisha Gandhi; Vijaya Chaturvedi; Eric P Smith; Sandy Schwemberger; Andrew Osterburg; George F Babcock; Yaron Tomer
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

3.  Role of polymorphic residues of human leucocyte antigen-DR molecules on the binding of human immunodeficiency virus peptides.

Authors:  S Jurcevic; C Praud; H L Coppin; A Bertrand; S Ricard; M Thomsen; F Lakhdar-Ghazal; C De Preval
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

4.  The I-Ab-restricted alloresponse of D10.G4.1 T cells is based on the recognition of an endogenous peptide.

Authors:  G Gradehandt; N Kleber; F Mattner; S Milbradt; E Rüde
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

Review 5.  Mechanism of cellular rejection in transplantation.

Authors:  Elizabeth Ingulli
Journal:  Pediatr Nephrol       Date:  2010-01       Impact factor: 3.714

6.  Optimizing PLG nanoparticle-peptide delivery platforms for transplantation tolerance using an allogeneic skin transplant model.

Authors:  Sahil Shah; Saeed Daneshmandi; Kevin R Hughes; Shuangjin Yu; Angela M Bedoya; Lonnie D Shea; Xunrong Luo
Journal:  Biomaterials       Date:  2019-05-01       Impact factor: 12.479

7.  Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation.

Authors:  Pervinder Sagoo; Giovanna Lombardi; Robert I Lechler
Journal:  Front Immunol       Date:  2012-07-13       Impact factor: 7.561

Review 8.  What Is Direct Allorecognition?

Authors:  Dominic A Boardman; Jacinta Jacob; Lesley A Smyth; Giovanna Lombardi; Robert I Lechler
Journal:  Curr Transplant Rep       Date:  2016-10-07

9.  HLA Amino Acid Polymorphisms and Kidney Allograft Survival.

Authors:  Malek Kamoun; Keith P McCullough; Martin Maiers; Marcelo A Fernandez Vina; Hongzhe Li; Valerie Teal; Alan B Leichtman; Robert M Merion
Journal:  Transplantation       Date:  2017-05       Impact factor: 4.939

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.